Vaccination is critical pillar of our Covid-19 response: Dr VK Paul

Dr VK Paul, a Niti Aayog member encouraged people to get vaccinated against coronavirus and said, 'vaccination is the critical pillar of our Covid-19 response and they are helpful to an extent'

Niti Aayog member-health V K Paul
Niti Aayog member-health V K Paul
ANI General News
2 min read Last Updated : Jan 12 2022 | 8:03 PM IST

Dr VK Paul, a Niti Aayog member, on Wednesday encouraged people to get vaccinated against coronavirus infection at the earliest and said, "vaccination is the critical pillar of our COVID-19 response and they are helpful to an extent".

Addressing the union health briefing here today, Dr VK Paul said, "Omicron is not the common cold. It's our responsibility to slow it down. Let's mask up and get vaccinated, whoever is due. It's fact they (vaccines) are helpful to an extent. Vaccination is the critical pillar of our COVID response."

Further, he emphasised the use of medicines and said that there should be a rational approach for medicine use.

"There should be a rational approach for medicine use. We are concerned about the overuse and misuse of drugs. Don't overuse. It will have an aftermath...Have warm water, do gargles in-home care," he added.

Speaking on the ban on physical election rallies, the health ministry said, "Election Commission has issued guidelines related to gathering, rallies. As the situation evolves, we coordinate with the EC. A decision will be taken accordingly."

Earlier on January 8, the Election Commission of India banned all the physical elections rallies till January 15 for the upcoming assembly polls in five states.

Meanwhile, with the administration of over 85 lakh doses of the COVID-19 vaccine in the last 24 hours, India's COVID-19 vaccination coverage has exceeded 153.80 crores as per provisional reports till 7 am today.

According to the Union Health Ministry, India administered 85,26240 doses, taking the total vaccination coverage to 1,53,80,08,200.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccine

First Published: Jan 12 2022 | 8:03 PM IST

Next Story